© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
electroCore, Inc. (ECOR) stock surged +9.29%, trading at $10.35 on NASDAQ, up from the previous close of $9.47. The stock opened at $9.45, fluctuating between $9.45 and $10.35 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 26, 2026 | 9.45 | 10.35 | 9.45 | 10.35 | 77.99K |
| Aug 25, 2026 | 9.56 | 9.97 | 9.23 | 9.47 | 109.29K |
| Aug 24, 2026 | 10.52 | 10.52 | 9.48 | 9.65 | 45.44K |
| Aug 21, 2026 | 10.33 | 10.95 | 10.00 | 10.52 | 59.94K |
| Aug 20, 2026 | 10.70 | 10.81 | 9.64 | 10.21 | 182.66K |
| Aug 19, 2026 | 10.35 | 10.93 | 9.85 | 10.81 | 73.5K |
| Aug 18, 2026 | 10.26 | 10.54 | 10.02 | 10.27 | 47.22K |
| Aug 17, 2026 | 10.15 | 10.68 | 10.00 | 10.25 | 144.33K |
| Aug 14, 2026 | 9.71 | 10.39 | 9.68 | 9.97 | 119.8K |
| Aug 13, 2026 | 9.53 | 10.05 | 8.74 | 9.94 | 109.37K |
| Aug 12, 2026 | 9.00 | 9.50 | 8.72 | 9.40 | 81.06K |
| Aug 11, 2026 | 8.79 | 9.37 | 8.66 | 9.12 | 76.56K |
| Aug 10, 2026 | 8.02 | 8.99 | 7.68 | 8.96 | 51.61K |
| Aug 07, 2026 | 6.70 | 8.82 | 6.35 | 8.09 | 213.99K |
| Aug 06, 2026 | 6.36 | 6.71 | 5.80 | 6.70 | 197.72K |
| Aug 05, 2026 | 6.36 | 6.56 | 6.10 | 6.53 | 25.89K |
| Aug 04, 2026 | 6.00 | 6.68 | 6.00 | 6.23 | 197.9K |
| Aug 03, 2026 | 6.03 | 6.33 | 5.74 | 6.09 | 143.88K |
| Jul 31, 2026 | 6.24 | 6.33 | 5.98 | 6.09 | 37.06K |
| Jul 30, 2026 | 6.14 | 6.61 | 6.01 | 6.29 | 59.41K |
electroCore, Inc. is a commercial-phase medical device enterprise whose focus lies in developing and bringing to market a variety of non-invasive vagus nerve stimulation (nVNS) therapies. Currently, the firm is advancing gammaCore, a prescription-only nVNS therapy specifically engineered for adults to acutely treat the discomfort associated with both migraine and episodic cluster headaches. Its flagship offering, the gammaCore Sapphire, is a portable, rechargeable, and refillable device intended for either regular or intermittent use over many years. Established in 2005, its corporate headquarters are situated in Rockaway, New Jersey.
| Employees | 83 |
| Beta | 0.94 |
| Sales or Revenue | $16.03M |
| 5Y Sales Change% | 4.71% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Devices |